Mistrulli, R.; Ferrera, A.; Muthukkattil, M.L.; Battistoni, A.; Gallo, G.; Barbato, E.; Spera, F.R.; Magrì, D.
Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication. J. Clin. Med. 2024, 13, 501.
https://doi.org/10.3390/jcm13020501
AMA Style
Mistrulli R, Ferrera A, Muthukkattil ML, Battistoni A, Gallo G, Barbato E, Spera FR, Magrì D.
Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication. Journal of Clinical Medicine. 2024; 13(2):501.
https://doi.org/10.3390/jcm13020501
Chicago/Turabian Style
Mistrulli, Raffaella, Armando Ferrera, Melwyn Luis Muthukkattil, Allegra Battistoni, Giovanna Gallo, Emanuele Barbato, Francesco Raffaele Spera, and Damiano Magrì.
2024. "Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication" Journal of Clinical Medicine 13, no. 2: 501.
https://doi.org/10.3390/jcm13020501
APA Style
Mistrulli, R., Ferrera, A., Muthukkattil, M. L., Battistoni, A., Gallo, G., Barbato, E., Spera, F. R., & Magrì, D.
(2024). Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication. Journal of Clinical Medicine, 13(2), 501.
https://doi.org/10.3390/jcm13020501
